Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.5K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-drug Antibody Sample Testing and Reporting Harmonization.

The AAPS journal·2022
Same author

A bridging immunogenicity assay for anti-cabiralizumab antibodies: overcoming the low assay cut point and drug tolerance challenges.

Bioanalysis·2021
Same author

Strategies for method comparison when changes in the immunogenicity method are needed within a clinical program.

Bioanalysis·2020
Same author

GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline.

Bioanalysis·2019
Same author

12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicity.

Bioanalysis·2019
Same author

Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.

Bioanalysis·2019

Related Experiment Video

Updated: Mar 19, 2026

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

20.4K

Old to new ligand-binding assay method modifications.

Bruce Stouffer1, Dennis Stocker2

  • 1PPD, Richmond, VA (previously BMS), USA.

Bioanalysis
|June 16, 2016
PubMed
Summary
This summary is machine-generated.

This article provides guidance on updating regulated ligand-binding assays for biologics drugs. It covers method validation and smooth transitions to newer technologies for PK and immunogenicity studies.

Keywords:
ELISAMSDPK methodsbioanalytical method modificationschange in critical reagentschange in platformcrossvalidationdrug toleranceimmunogenicity methodsligand-binding assay

More Related Videos

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

30.5K
Measuring Interactions of Globular and Filamentous Proteins by Nuclear Magnetic Resonance Spectroscopy NMR and Microscale Thermophoresis MST
10:28

Measuring Interactions of Globular and Filamentous Proteins by Nuclear Magnetic Resonance Spectroscopy NMR and Microscale Thermophoresis MST

Published on: November 2, 2018

12.7K

Related Experiment Videos

Last Updated: Mar 19, 2026

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

20.4K
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

30.5K
Measuring Interactions of Globular and Filamentous Proteins by Nuclear Magnetic Resonance Spectroscopy NMR and Microscale Thermophoresis MST
10:28

Measuring Interactions of Globular and Filamentous Proteins by Nuclear Magnetic Resonance Spectroscopy NMR and Microscale Thermophoresis MST

Published on: November 2, 2018

12.7K

Area of Science:

  • Biopharmaceutical analysis
  • Analytical chemistry
  • Regulatory science

Background:

  • Ligand-binding assays (LBAs) are critical for biologics drug development.
  • Method changes in LBAs require careful validation to meet regulatory standards.
  • Existing methods may need updates due to technological advancements or performance limitations.

Purpose of the Study:

  • To outline strategies for validating method changes in regulated LBAs.
  • To guide the transition from older to newer LBA formats and technologies.
  • To ensure compliance with current industry expectations and regulatory requirements.

Main Methods:

  • Review of different ligand-binding assay formats.
  • Discussion of reasons for method updates.
  • Description of procedures for qualifying method changes in immunoassays.
  • Inclusion of case studies and literature references.

Main Results:

  • Provides a framework for understanding, characterizing, and validating LBA method changes.
  • Offers practical examples and guidance for smooth transitions.
  • Highlights challenges and solutions in updating analytical methods for biologics.

Conclusions:

  • Properly validated method changes are essential for reliable PK and immunogenicity data.
  • Adopting newer, robust, or sensitive methods can enhance biologics drug analysis.
  • Strategic planning facilitates successful transitions of analytical methods.